The combined usage of accurate virological and serological HBV markers can help to identify HBsAg-negative/anti-HBc-positive patients at higher risk of HBV-reactivation and to optimize prophylaxis duration in oncohematological setting

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2020-02, Vol.52, p.e23-e23
Main Authors: Salpini, R., Alkhatib, M., Cerva, C., Piermatteo, L., Battisti, A., Malagnino, V., Fabeni, L, Cantonetti, M.L., Arcese, W., Ceccherini-Silberstein, F., Perno, C.F., Andreoni, M., Sarmati, L., Svicher, V.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1590-8658
1878-3562
DOI:10.1016/j.dld.2019.12.101